ArticlePloS one2026

Expression of Concern: TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.